Cite

HARVARD Citation

    Ghosh, T. et al. (n.d.). P472 Payer addressable burden of Crohn's disease in patients treated with ustekinumab and vedolizumab in the United States. Journal of Crohn's and colitis. pp. S461-S462. [Online]. 
  
Back to record